Dendritic Cells as a Tool for the Predictive Identification of Skin Sensitisation Hazard

Buehler E.V. (1965). Delayed contact hypersensitivity in the guinea pig. Archives of Dermatology 91, 171–177.

Magnusson B. , & Kligman A.M. (1970). Allergic Contact Dermatitis in the Guinea Pig: Identification of Contact Allergens, 141 pp. Springfield, IL, USA: Charles C Thomas.

Kimber I. , Dearman R.J. , Basketter D.A. , Ryan C.A. , & Gerberick G.F. (2002). The local lymph node assay: past, present and future. Contact Dermatitis 47, 315–328.

Kimber I. , Pichowski J.S. , Basketter D.A. , & Dearman R.J. (1999). Immune responses to contact allergens: novel approaches to hazard evaluation. Toxicology Letters 106, 237–246.

Kimber I. , Pichowski J.S. , Betts C.J. , Cumberbatch M. , Basketter D.A. , & Dearman R.J. (2001). Alternative approaches to the identification and characterization of chemical allergens. Toxicology in Vitro 15, 307–312.

Ryan C.A. , Hulette B.C. , & Gerberick G.F. (2001). Approaches for the development of cell-based in vitro methods for contact sensitisation. Toxicology in Vitro 15, 43–55.

Kimber I. , Cumberbatch M. , Betts C.J. , & Dearman R.J. (2004). Dendritic cells and skin sensitisation hazard assessment. Toxicology in Vitro 18, 195–202.

Grabbe S. , & Schwarz T. (1998). Immunoregulatory mechanisms involved in the elicitation of allergic contact hypersensitivity. Immunology Today 19, 37–44.

Kimber I. , Basketter D.A. , Gerberick G.F. , & Dearman R.J. (2002). Allergic contact dermatitis. International Immunopharmacology 2, 201–211.

Kimber I. , & Dearman R.J. (2002). Allergic contact dermatitis: the cellular effectors. Contact Dermatitis 46, 1–5.

Sebastiani S. , Albanesi C. , De Pita O. , Puddu P. , Cavani A. , & Girolomoni G. (2002). The role of chemokines in allergic contact dermatitis. Archives of Dermatological Research 293, 552–559.

Dearman R.J. , & Kimber I. (2003). Factors influencing the induction phase of skin sensitisation. Americal Journal of Contact Dermatitis 14, 188–194.

Friedmann P.S. (1981). The immunobiology of Langerhans cells. Immunology Today 2, 124–128.

Kimber I. , & Cumberbatch M. (1992). Dendritic cells and cutaneous immune responses to chemical allergens. Toxicology and Applied Pharmacology 117, 137–146.

Kimber I. , Dearman R.J. , Cumberbatch M. , & Huby R.J.D. (1998). Langerhans cells and chemical allergy. Current Opinion in Immunology 10, 614–619.

Kimber I. , Cumberbatch M. , Dearman R.J. , Bhushan M. , & Griffiths C.E.M. (2000). Cytokines and chemokines in the initiation and regulation of epidermal Langerhans cell mobilization. British Journal of Dermatology 142, 401–412.

Maurer D. , & Stingl G. (2001). Lagerhans cells. In Dendritic Cells: Biology and Clinical Applications (ed. Lotze M.T. , & Thomson A.W. ), 2nd edn, pp. 35–50. San Diego, CA, USA: Academic Press.

Cumberbatch M. , Dearman R.J. , Griffiths C.E.M. , & Kimber I. (2000). Langerhans cell migration. Clinical and Experimental Dermatology 25, 413–418.

Cumberbatch M. , Dearman R.J. , Griffiths C.E.M. , & Kimber I. (2003). Epidermal Langerhans cell migration and sensitisation to chemical allergens. Acta Pathologica, Microbiologica et Immunologica Scandinavica 111, 797–804.

Kimber I. , Cumberbatch M. , Dearman R.J. , & Griffiths C.E.M. (2002). Danger signals and skin sensitisation. British Journal of Dermatology 147, 613–614.

Enk A.H. , & Katz S.I. (1992). Early molecular events in the induction phase of contact sensitivity. Proceedings of the National Academy of Sciences USA 89, 1398–1402.

de Silva O. , Basketter D.A. , Barratt M.D. , Corsini E. , Cronin M.T.D. , Das P.K. , Degwert J. , Enk A. , Garrigue J.L. , Hauser C. , Kimber I. , Lepoittevin J-P. , Peguet J. , & Ponec M. (1996). Alternative methods for skin sensitisation testing. The report and recommendations of ECVAM workshop 19. ATLA 24, 683–705.

Enk A.H. , Angeloni V.L. , Udey M.C. , & Katz S.I. (1993). An essential role of Langerhans cell-derived IL-1β in the initiation of primary immune responses in skin. Journal of Immunology 150, 3698–3704.

Shornick L.P. , De Togni P. , Mariathasan S. , Goellner J. , Strauss-Schoenberger J. , Karr R.W. , Ferguson T.A. , & Chaplin D.D. (1996). Mice deficient in IL-1β manifest impaired contact hypersensitivity to trinitrochlorobenzene. Journal of Experimental Medicine 183, 1427–1436.

Cumberbatch M. , Dearman R.J. , & Kimber I. (1997). Langerhans cells require signals from both tumour necrosis factor-α and interleukin-1β for migration. Immunology 92, 388–395.

Reutter K. , Jager D. , Degwert J. , & Hoppe U. (1997). In vitro model for contact sensitisation. II. Induction of IL-1β mRNA in human blood-derived dendritic cells by contact sensitisers. Toxicology in Vitro 11, 619–626.

Pichowski J.S. , Cumberbatch M. , Dearman R.J. , Basketter D.A. , & Kimber I. (2000). Investigation of induced changes in interleukin 1β mRNA expression by cultured human dendritic cells as an in vitro approach to skin sensitisation testing. Toxicology in Vitro 14, 351–360.

Pichowski J.S. , Cumberbatch M. , Dearman R.J. , Basketter D.A. , & Kimber I. (2001). Allergen-induced changes in interleukin 1 beta (IL-1 beta) mRNA expression by human blood-derived dendritic cells: inter-individual differences and relevance for sensitisation testing. Journal of Applied Toxicology 21, 115–121.

De Smedt A.C.A. , Van Den Heuvel R.L. , Van Tendeloo V.F.I. , Berneman Z.N. , Schoeters G.E.R. , Weber E. , & Tuschl H. (2002). Phenotypic alterations and IL-1β production in CD34⁺ progenitor- and monocyte-derived dendritic cells after exposure to allergens: a comparative analysis. Archives of Dermatological Research 294, 109–116.

Strunk D. , Rappersberger K. , Egger C. , Strobl H. , Krömer E. , Elbe A. , Maurer D. , & Stingl G. (1996). Generation of human dendritic cells/Langerhans cells from circulating CD34⁺ hematopoietic progenitor cells. Blood 87, 1292–1302.

Santiago-Schwarz F. , Belios E. , Diamond B. , & Carson S.E. (1992). TNF in combination with GM-CSF enhances the differentiation of neonatal cord blood cells into dendritic cells and macrophages. Journal of Leucocyte Biology 52, 274–281.

Caux C. , Vanbervliet B. , Massacrier C. , Dezutter-Dambuyant C. , de Saint-Vis B. , Jacquet C. , Yoneda K. , Imamura S. , Schmitt D. , & Banchereau J. (1996). CD34⁺ hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to GM-CSF+TNF-α. Journal of Experimental Medicine 184, 695–706.

Arrighi J.F. , Hauser C. , Chapuis B. , Zubler R. , & Kindler V. (1999). Long-term culture of human CD34+ progenitors from FLT3-ligand, thrombopoietin, and stem cell factor induces extensive amplification of a CD34-CD14– and a CD34-CD14+ dendritic cell precursor. Blood 93, 2244–2252.

Curti A. , Fogli M. , Ratta M. , Tura S. , & Lemoli R.M. (2001). Stem cell factor and FLT3-ligand are strictly required to sustain the long-term expansion of primitive CD34⁺DR^– dendritic cell precursors. Journal of Immunology 166, 848–854.

Jaksits S. , Kriehuber E. , Charbonnier A.S. , Rappersberger K. , Stingl G. , & Maurer D. (1999). CD34+ cell-derived CD14+ precursor cells develop into Langerhans cells in a TGF-β1-dependent manner. Journal of Immunology 163, 4869–4877.

Ferlazzo G. , Wesa A. , Wei W.Z. , & Galy A. (1999). Dendritic cells generated from CD34+ progenitor cells or from monocytes differ in their ability to activate antigen-specific CD8+ T cells. Journal of Immunology 163, 3597–3604.

Sallusto F. , & Lanzavecchia A. (1994). Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony stimulating factor plus interleukin-4 and down-regulated by tumor necrosis factor alpha. Journal of Experimental Medicine 179, 1109–1118.

Sallusto F. , Cella M. , Danieli C. , & Lanzavecchia A. (1995). Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: down-regulation by cytokines and bacterial products. Journal of Experimental Medicine 182, 389–400.

Snijders A. , Kalinski P. , Hilkens C.M. , & Kapsenberg M.L. (1998). High-level IL-12 production by human dendritic cells requires two signals. International Immunology 10, 1593–1598.

Santini S.M. , Lapenta C. , Logozzi M. , Parlato S. , Spada M. , Di Pucchio T. , & Belardelli F. (2000). Type I interferon as a powerful adjuvant for monocyte-derived dendritic cell development and activity in vitro and in Hu-PBL-SCID mice. Journal of Experimental Medicine 15, 1777–1788.

Geissmann F. , Prost C. , Monnet J.P. , Dy M. , Brousse N. , & Hermine O. (1998). Transforming growth factor beta 1, in the presence of granulocyte/macrophage colony-stimulating factor and interleukin 4, induces differentiation of human peripheral blood monocytes into dendritic Langerhans cells. Journal of Experimental Medicine 16, 961–966.

Verrier A.C. , Schmitt D. , & Staquette M-J. (1999). Fragrance and contact allergens in vitro modulate the HLA-DR and E-cadherin expression on human epidermal Langerhans cells. International Archives of Allergy and Immunology 120, 56–62.

Rizova H. , Carayon P. , Barbier A. , Lacheretz F. , Dubertret L. , & Michel L. (1999). Contact allergens, but not irritants, alter receptor-mediated endocytosis by human epidermal Langerhans cells. British Journal of Dermatology 140, 200–209.

Tuschl H. , & Kovac R. (2001). Langerhans cells and immature dendritic cells as model systems for screening of skin sensitisers. Toxicology in Vitro 15, 327–331.

Degwert J. , Steckel F. , Hoppe U. , & Kligman L.H. (1997). In vitro model for contact sensitisation. I. Stimulatory capacities of human blood-derived dendritic cells and their phenotypical alterations in the presence of contact sensitisers. Toxicology in Vitro 11, 613–618.

Becker D. , Kühn U. , Lempertz U. , Enk A. , Saloga J. , & Knop J. (1997). Flow-cytometric screening for the modulation of receptor-mediated endocytosis in human dendritic cells: implications for the development of an in vitro technique for predictive testing of contact sensitisers. Journal of Immunological Methods 203, 171–180.

Aiba S. , Terunuma A. , Manome H. , & Tagami H. (1997). Dendritic cells differently respond to haptens and irritants by their production of cytokines and expression of co-stimulatory molecules. European Journal of Immunology 27, 3031–3038.

Aiba S. , Manome H. , Yoshino Y. , & Tagami H. (2000). In vitro treatment of human transforming growth factor-1β-treated monocyte-derived dendritic cells with haptens can induce the phenotypic and functional changes similar to epidermal Langerhans cells in the initiation phase of allergic contact sensitivity reaction. Immunology 101, 68–75.

Coutant K.D. , de Brugerolle de Fraissinette A. , Cordier A. , & Ulrich P. (1999). Modulation of the activity of human monocyte-derived dendritic cells by chemical haptens, a metal alleren, and a Staphylococcal superantigen. Toxicological Sciences 52, 189–198.

Manome H. , Aiba S. , & Tagami H. (1999). Simple chemicals can induce maturation and apoptosis of dendritic cells. Immunology 98, 481–490.

Hulette B.C. , Ryan C.A. , & Gerberick G.F. (2002). Elucidating changes in surface marker expression of dendritic cells following chemical allergen treatment. Toxicology and Applied Pharmacology 182, 226–233.

Staquet M.J. , Sportouch M. , Jacquet C. , Schmitt D. , Guesnet J. , & Péguet-Navarro J. (2004). Moderate skin sensitisers can induce phenotypic changes on in vitro generated dendritic cells. Toxicology in Vitro 18, 493–500.

Aeby P. , Wyss C. , Beck H. , Griem P. , Scheffler H. , & Goebel C. (2004). Characterization of the sensitizing potential of chemicals by in vitro analysis of dendritic cell activation and skin penetration. Journal of Investigative Dermatology 122, 1154–1164.

Rougier N. , Redziniak G. , Schmitt D. , & Vincent C. (1998). Evaluation of the capacity of dendritic cells derived from cord blood CD34⁺ precursors to present haptens to unsensitized autologous T cells in vitro. Journal of Investigative Dermatology 110, 348–352.

Rougier N. , Redziniak G. , Mougin D. , Schmitt D. , & Vincent C. (2000). In vitro evaluation of the sensitisation potential of weak contact allergens using langerhans-like dendritic cells and autologous T cells. Toxicology 145, 73–82.

De Smedt A.C.A. , Van Den Heuvel R.L. , Bernemen Z.N. , & Schoeters G.E.R. (2001). Modulation of phenotype, cytokine production and stimulatory function of CD34+ cell-derived DC by NiCl₂ and SDS. Toxicology in Vitro 15, 319–325.

De Smedt A.C.A. , Van Den Heuvel R.L. , Van Tendeloo V.F.I. , Berneman Z.N. , & Schoeters G.E.R. Capacity of CD34+ progenitor-derived dendritic cells to distinguish between sensitisers and irritants. Toxicology Letters, in press.

Boislève F. , Kerdine-Römer S. , Rougier-Larzat N. , & Pallardy M. (2004). Nickel and DNCB induce CCR7 expression on human dendritic cells through different signalling pathways: role of TNF-α and MAPK. Journal of Investigative Dermatology 123, 494–502.

Boislève F. , Kerdine-Römer S. , & Pallardy M. (2004). Implication of the MAPK pathways in the maturation of human dendritic cells induced by nickel and TNF-α. Toxicology 206, 233–244.

Dietz A.B. , Bulur P.A. , Knutson G.J. , Matasic R. , & Vuk-Pavlovic S. (2000). Maturation of human monocyte-derived dendritic cells studied by microarray hybridization. Biochemical and Biophysical Research Communications 275, 731–738.

Le Naour F. , Hohenkirk L. , Grolleau A. , Misek D.E. , Lescure P. , Geiger J.D. , Hanash S. , & Beretta L. (2001). Profiling changes in gene expression during differentiation and maturation of monocyte-derived dendritic cells using both oligonucleotide microarrays and proteomics. Journal of Biological Chemistry 276, 17,920–17,931.

Moschella F. , Maffei A. , Catanzaro R.P. , Papadopoulos K.P. , Skerrett D. , Hesdorfer C.S. , & Harris P.E. (2001). Transcript profiling of human dendritic cells maturation-induced under defined culture conditions: comparison of the effects of tumour necrosis factor alpha, soluble CD40 ligand trimer and interferon gamma. British Journal of Haematology 114, 444–457.

Chen Z. , Gordon J.R. , Zhang X. , & Xiang J. (2002). Analysis of the gene expression profiles of immature versus mature bone-marrow-derived dendritic cells using DNA arrays. Biochemical and Biophysical Research Communications 290, 66–72.

Lindstedt M. , Johansson-Lindbom B. , & Borrebaeck C.A.K. (2002). Global reprogramming of dendritic cells in response to a concerted action of inflammatory mediators. International Immunology 14, 1203–1213.

Messmer D. , Messmer B. , & Chiorazzi N. (2003). The global transcriptional maturation program and stimuli-specific gene expression profiles of human myeloid dendritic cells. International Immunology 15, 491–503.

Türeci O. , Bian H. , Nestle F.O. , Raddrizzani L. , Rosinski J.A. , Tassis A. , Hilton H. , Walstead M. , Sahin U. , & Hammer J. (2003). Cascades of transcriptional induction during dendritic cell maturation revealed by genome-wide expression analysis. FASEB Journal 17, 836–847.

Ryan C.A. , Gildea L.A. , Hulette B.C. , Dearman R.J. , Kimber I. , & Gerberick G.F. (2004). Gene expression changes in peripheral blood-derived dendritic cells following exposure to a contact allergen. Toxicology Letters 150, 301–316.

Kühn U. , Brand P. , Willemsen J. , Jonuleit H. , Enk A.H. , van Brandwijk-Peterhans R. , Saloga J. , Knop J. , & Becker D. (1998). Induction of tyrosine phosphorylation in human MHC Class II-positive antigen-presenting cells by stimulation with contact sensitisers. Journal of Immunology 160, 667–673.

Ardeshna K.M. , Pizzey A.R. , Devereux S. , & Khwaja A. (2000). The PI3 kinase, p38 SAP kinase, and NF-kappaB signal transduction pathways are involved in the survival and maturation of lipopolysaccharide-stimulated human monocyte-derived dendritic cells. Blood 96, 1039–1046.

Underhill D.M. , & Ozinsky A. (2002). Toll-like receptors: key mediators of microbe detection. Current Opinion in Immunology 14, 103–110.

Dunne A. , & O'Neill L. A. (2003). The interleukin-1 receptor/Toll-like receptor superfamily: signal transduction during inflammation and host defense. Science's STKE 2003 (171), re3.

Aiba S. , Manome H. , Nakagawa S. , Mollah Z.U. , Mizuashi M. , Ohtani T. , Yoshino Y. , & Tagami H. (2003). p38 Mitogen-activated protein kinase and extracellular signal-regulated kinases play distinct roles in the activation of dendritic cells by two representative haptens, NiCl₂ and 2,4-dinitrochlorobenzene. Journal of Investigative Dermatology 120, 390–399.

Arrighi J. F. , Rebsamen M. , Rousset F. , Kindler V. , & Hauser C. (2001). A critical role for p38 mitogen-activated protein kinase in the maturation of human blood-derived dendritic cells induced by lipopolysaccharide TNF-alpha and contact sensitisers. Journal of Immunology 166, 3837–3845.

Bennett B.L. , Sasaki D.T. , Murray B.W. , O'Leary E.C. , Sakata S.T. , Xu W. , Leisten J.C. , Motiwala A. , Pierce S. , Satoh Y. , Bhagwat S.S. , Manning A.M. , & Anderson D.W. (2001). SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase. Proceedings of the National Academy of Sciences USA 98, 13,681–13,686.

Laderach D. , Compagno D. , Danos O. , Vainchenker W. , & Galy A. (2003). RNA interference shows critical requirement for NF-kappa B p50 in the production of IL-12 by human dendritic cells. Journal of Immunology 15, 1750–1757.

Luft T. , Jefford M. , Luetjens P. , Toy T. , Hochrein H. , Masterman K.A. , Maliszewski C. , Shortman K. , Cebon J. , & Maraskovsky E. (2002). Functionally distinct dendritic cell (DC) populations induced by physiologic stimuli: prostaglandin E(2) regulates the migratory capacity of specific DC subsets. Blood 100, 1362–1372.

Scandella E. , Men Y. , Gillessen S. , Forster R. , & Groettrup M. (2002). Prostaglandin E2 is a key factor for CCR7 surface expression and migration of monocyte-derived dendritic cells. Blood 100, 1354–1361.

Bour H. , Peyron E. , Gaucherand M. , Garrigue J.L. , Desvignes C. , Kaiserlian D. , Revillard J.P. , & Nicolas J.F. (1995). Major histocompatibility complex class I-restricted CD8+ T cells and class II-restricted CD4⁺ T cells, respectively, mediate and regulate contact sensitivity to dinitrofluorobenzene. European Journal of Immunology 25, 3005–3010.

Anderson C. , Hehr A. , Robbins R. , Hasan R. , Athar M. , Mukhtar H. , & Craig E. (1995). Metabolic requirements for induction of contact hypersensitivity to immunotoxic polyaromatic hydrocarbons. Journal of Immunology 155, 3530–3535.

Xu H. , Dilulio N.A. , & Fairchild R.L. (1996). T cell populations primed by hapten sensitisation in contact sensitivity are distinguished by polarized patterns of cytokine production: interferon gamma-producing (Tc1) effector CD8+ T cells and interleukin (IL) 4/IL-10-producing (Th2) negative regulatory CD4+ T cells. Journal of Experimental Medicine 183, 1001–1012.

Moulon C. , Wild D. , Dormoy A. , & Weltzien H.U. (1998). MHC-dependant and independent activation of human nickel-specific CD8+ cytotoxic T cells from allergic donors. Journal of Investigative Dermatology 111, 360–366.

Hauser C. , & Katz S.I. (1990). Generation and characterization of T-helper cells by primary in vitro sensitisation using Langerhans cells. Immunological Reviews 117, 67–84.

Moulon C. , Peguet-Navarro J. , Courtellemont P. , Redziniak G. , & Schmitt D. (1993). In vitro primary sensitisation and restimulation of hapten-specific T cells by fresh and cultured epidermal Langerhans’ cells. Immunology 80, 373–379.

Krasteva M. , Peguet-Navarro J. , Moulon C. , Courtellemont P. , Redziniak G. , & Schmitt D. (1996). In vitro primary sensitisation of hapten-specific T cells by cultured human epidermal Langerhans cells: a screening predictive assay for contact sensitisers. Clinical and Experimental Allergy 26, 563–570.

Streilein J.W. , & Grammer S.F. (1989). In vitro evidence that Langerhans cells can adopt two functionally distinct forms capable of antigen presentation to T lymphocytes. Journal of Immunology 143, 3925–3933.

Puré E. , Inaba K. , & Crowley M.T. (1990). Antigen processing by epidermal Langerhans cells correlates with the level of biosynthesis of major histocompatibility complex class II molecules and expression of invariant chain. Journal of Experimental Medicine 172, 1459–1469.

Romani N. , Gruner S. , Brang D. , Kampgen E. , Lenz A. , Trockenbacher B. , Konwalika G. , Fritsch P.O. , Steinman R.M. , & Schuler G. (1994). Proliferating dendritic cell progenitors in human blood. Journal of Experimental Medicine 180, 83–93.

Caux C. , Massacrier C. , Dezutter-Dambuyant C. , Vanbervliet B. , Jacquet C. , Schmitt D. , & Banchereau J. (1995). Human dendritic cells Langerhans cells generated in vitro from CD34+ progenitors can prime naïve CD4+ T cells and process soluble antigen. Journal of Immunology 155, 5427–5435.

Rustemeyer T. , De Ligter S. , Von Blomberg B.M. , Frosch P.J. , & Scheper R.J. (1999). Human T lymphocyte priming in vitro by haptenated autologous dendritic cells. Clinical and Experimental Immunology 117, 209–216.

Dai R. , & Streinlein J.W. (1998). Naïve, hapten-specific human T lymphocytes are primed in vitro with derivatized blood mononuclear cells. Journal of Investigative Dermatology 110, 29–33.

Guironnet G. , Dalbiez-Gauthier C. , Rousset F. , Schmitt D. , & Peguet-Navarro J. (2000). In vitro human T cell sensitisation to haptens by monocyte-derived dendritic cells. Toxicology in Vitro 14, 517–522.

Opdyke D.L.J. (1975). Monograph on fragrance raw material. Food and Cosmetics Toxicology 13, 681–923.

De Groot A.C. , Liem D.H. , Nater J.P. , & van Ketel W.G. (1985). Patch tests with fragrance materials and preservatives. Contact Dermatitis 12, 87–92.

Larsen W. , Nakayama H. , Lindberg M. , Fisher T. , Elsner P. , Burrows D. , Jordan W. , Shaw S. , Wilkinson J. , Marks J. Jr. , Sugawara M. , & Nethercott J. (1996). Fragrance contact dermatitis: a worldwide multicenter investigation (Part I). American Journal of Contact Dermatitis 7, 77–83.

Larsen W.G. (2002). Fragrance testing in the 21st century. Contact Dermatitis 46, 60–61.

Johansen J.D. , Andersen T.F. , Kjoller M. , Veien N. , Avnstorp C. , Andersen K.E. , & Menne T. (1998). Identification of risk products for fragrance contact allergy: a case-referent study based on patient's histories. American Journal of Contact Dermatitis 9, 80–86.

Goodwin B.J.F. , Crevel R.W.R. , & Johnson A.W. (1981). A comparison of three guinea pig sensitisation procedures for the detection of 19 reported human contact sensitisers. Contact Dermatitis 7, 248–258.

Marzulli F.N. , & Maibach H.I. (1974). The use of graded concentrations in studying skin sensitisers: experimental contact sensitisation in man. Food and Cosmetics Toxicology 12, 219–227.

Basketter D.A. , & Scholes E.W. (1992). Comparison of the local lymph node assay with the guinea pig maximization test for the detection of a range of contact allergens. Food and Cosmetics Toxicology 30, 65–69.

Basketter D.A. , & Liden C. (1992). Further investigation on the prohapten concept: reactions to benzene derivative in man. Contact Dermatitis 27, 90–97.

Régnier M. , Staquet M.J. , Schmitt D. , & Schmidt R. (1997). Integration of Langerhans cells into a pigmented reconstructed human epidermis. Journal of Investigative Dermatology 109, 510–512.

Sivard P. , Dezutter-Dambuyant C. , Kanitakis J. , Mosnier J.F. , Hamzeh H. , Bechetoille N. , Berthier O. , Sabido O. , Schmitt D. , Genin C. , & Misery L. (2003). In vitro reconstructed mucosa-integrating Langerhans cells. Experimental Dermatology 2, 346–355.

Ayehunie S. , Cannon C.L. , Lamore S. , Kubilus J. , LaBonte J. , Pudney J. , Anderson D. , Sodroski J. , & Klausner M. (2002). Organotypic ectocervico-vaginal tissue model containing dendritic cells. Microbicide 2002 Meeting, Antwerp, Belgium, 12–15 May 2002, 9 pp. Website http://www.cdnaids.ca/web/mailouts.nsf/0/85f80b6904867adb85256c62006522e0/$FILE/ReportMicrobiocides2002.pdf (Accessed 24.2.05).

Facy S. , Flouret V. , Regnier M. , & Schmidt R. (2004). Langerhans cells integrated into human recontructed epidermis respond to known sensitisers and ultraviolet exposure. Journal of Investigative Dermatology 122, 552–553.

Schempp C.M. , Dittmar H.C. , Hummier D. , Simon-Haarhaus B. , Schulte-Monting J. , Schopf E. , & Simon J.C. (2000). Magnesium ions inhibit the antigen-presenting function of human epidermal Langerhans cells in vivo and in vitro. Involvement of ATPase, HLA-DR, B7 molecules, and cytokines. Journal of Investigative Dermatology 115, 680–686.

Larsen C.P. , Steinman R.M. , Witmer-Pack M. , Hankins D.F. , Morris P.J. , & Austyn J.M. (1990). Migration and maturation of Langerhans cells in skin transplants and explants. Journal of Experimental Medicine 172, 1483–1493.

Herouet C. , Cottin M. , Leclaire J. , Enk A. , & Rousset F. (2000). Contact sensitisers specifically increase MHC class II expression on immature dendritic cells. In Vitro and Molecular Toxicology 13, 113–123.

St Louis D.C. , Woodcock J.B. , Fransozo G. , Blair P.J. , Carlson L.M. , Murillo M. , Wells M.R. , Williams A.J. , Smoot D.S. , Kaushal S. , Grimes J.L. , Harlan D.M. , Chute J.P. , June C.H. , Siebenlist U. , & Lee K.P. (1999). Evidence for distinct intracellular signaling pathways in CD34+ progenitor to dendritic cell differentiation from a human cell line model. Journal of Immunology 162, 3237–3248.

Ashikaga T. , Hoya M. , Itagaki H. , Katsumura Y. , & Aiba S. (2002). Evaluation of CD86 expression and MHC class II molecule internalization in THP-1 human monocyte cells as predictive endpoints for contact sensitisers. Toxicology in Vitro 16, 711–716.

Yoshida Y. , Sakaguchi H. , Ito Y. , Okuda M. , & Suzuki H. (2003). Evaluation of the skin sensitisation potential of chemicals using expression of co-stimulatory molecules, CD54 and CD86, on the naive THP-1 cell line. Toxicology in Vitro 17, 221–228.

Koss A. , Lucero G. , & Koziner B. (1996). Granulocyte-colony stimulating factor, granulocyte-macrophage colony stimulating factor and interleukin 4 induce differentiation in the U-937 human monocytic leukemia cell line. Leukemia and Lymphoma 22, 163–171.

Tenno T. , Oberg F. , Nilsson K. , & Siegbahn A. (1997). Induction of differentiation in U-937 and NB4 cells is associated with inhibition of tissue factor production. European Journal of Haematology 63, 112–119.

OECD (2002). OECD Guidelines for the Testing of Chemicals, No. 429, The Local Lymph Node Assay, 7 pp. Paris, France: Organization for Economic Cooperation and Development.

Ryan C.A. , Cruse L.W. , Skinner R.A. , Dearman R.J. , Kimber I. , & Gerberick G.F. (2002). Examination of a vehicle for use with water soluble materials in the murine local lymph node assay. Food and Chemical Toxicology 40, 1719–1725.

Gerberick G.F. , Ryan C.A. , Kimber I. , Dearman R.J. , Lea L.J. , & Basketter D.A. (2000). Local lymph node assay validation assessment for regulatory purposes. American Journal of Contact Dermatitis 11, 3–18.

NIH (1999). The Murine Local Lymph Node Assay: A Test Method for Assessing the Allergic Contact Dermatitis Potential of Chemicals/Compounds. NIH No. 99-4494. 211 pp. Bethesda, MD, USA: National Institutes of Health.

Gerberick G.F. , Robinson M.K. , Ryan C.A. , Dearman R.J. , Kimber I. , Basketter D.A. , Wright Z.M. , & Marks J.G. (2001). Contact allergenic potency: correlation of human and local lymph node assay data. American Journal of Contact Dermatitis 12, 156–161

Smith C.K. , & Hotchkiss S.A. (2001). Allergic Contact Dermatitis. Chemical and Metabolic Mechanisms, 310 pp. London, UK: Taylor & Francis.

Smith-Pease C.K. , Basketter D.A. , & Patlewicz G.Y. (2003). Contact allergy: the role of skin chemistry and metabolism. Clinical and Experimental Dermatology 2, 1777–1783.

Basketter D.A. , Scholes E.W. , Evans C.D. , & Kimber I. (1992). Divergent responses to sulphanilic acid in the guinea pig maximization test and the local lymph node assay. Contact Dermatitis 27, 209–213.

Wahlberg J.E. (1989). Nickel: animal sensitisation assays. Nickel and skin. In Immunobiology and Toxicology (ed. Maibach H.I. , & Menné T. ), pp. 65–74. Boca Raton, FL, USA: CRC Press.

Basketter D.A. , Lea L. , Cooper K. , Ryan C.J. , Gerberick G.F. , Dearman R.J. , & Kimber I. (1999). The identification of metal allergens in the local lymph node assay. American Journal of Contact Dermatitis 10, 207–212.

Lepoittevin J-P. , Basketter D.A. , Dooms-Goossens A. , & Karlberg A-T. (1997). Allergic Contact Dermatitis: The Molecular Basis, 186 pp. Heidelberg, Germany: Springer-Verlag.

Thierse H.J. , Moulon C. , Allespach Y. , Zimmermann B. , Doetze A. , Kuppig S. , Wild D. , Herberg F. , & Weltzien H.U. (2004). Metal-protein complex-mediated transport and delivery of Ni2+ to TCR/MHC contact sites in nickel-specific human T cell activation. Journal of Immunology 172, 1926–1934.

Basketter D.A. , Pease Smith C.K. , & Patlewicz G.Y. (2003). Contact allergy: the local lymph node assay for the prediction of hazard and risk. Clinical and Experimental Dermatology 28, 218–221.

Felter S.P. , Ryan C.A. , Basketter D.A. , & Gerberick G.F. (2003). Application of the risk assessment paradigm to the induction of allergic contact dermatitis. Regulatory Toxicology and Pharmacology 37, 1–10.

Dearman R.J. , Smith S. , Basketter D.A. , & Kimber I. (1997). Classification of chemical allergens according to cytokine secretion profiles of murine lymph node cells. Journal of Applied Toxicology 17, 53–62.